Literature DB >> 28776748

Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori.

A G Fraser1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28776748     DOI: 10.1111/apt.14198

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  1 in total

Review 1.  Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases.

Authors:  Xiaoxiao Yang; Yueyue Li; Yiyuan Sun; Mingming Zhang; Chuanguo Guo; Iqtida Ahmed Mirza; Yan-Qing Li
Journal:  Dig Dis Sci       Date:  2017-12-27       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.